Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1401 of 5804
-
Smart prosthetic legs learn to walk naturally
Knowledge-focused Recruiting nowThe overall goal of this project is to model human joint biomechanics over continuously-varying locomotion to enable adaptive control of powered above-knee prostheses. The central hypothesis of this project is that variable joint impedance can be parameterized by a continuous mod…
Phase: NA • Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Could a tiny implant replace monthly eye shots for wet AMD?
Disease control OngoingThe primary purpose of this study is to evaluate the safety and durability of single- and repeat administration of AR-14034 Sustained Release (SR) in subjects with neovascular age-related macular degeneration (nAMD).
Phase: PHASE1, PHASE2 • Sponsor: Alcon Research • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New radioactive nanoparticle targets tough tumors in early trial
Disease control Recruiting nowThe purpose of this first-in-human (FIH) study is to determine the maximum tolerated dose (MTD) and to characterize the safety, tolerability, PK, and dosimetry profile of \[177Lu\]Lu-SN201 in adult participants with advanced solid tumors who have no standard of care treatment opt…
Phase: PHASE1, PHASE2 • Sponsor: Spago Nanomedical AB • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Spinal stimulation showdown: which technique helps paralyzed patients stand?
Knowledge-focused Recruiting nowIt has been demonstrated that the human lumbosacral spinal cord can be neuromodulated with epidural (ESS) and transcutaneous (TSS) spinal cord stimulation to enable recovery of standing and volitional control of the lower limbs after complete motor paralysis due to spinal cord in…
Phase: NA • Sponsor: The Methodist Hospital Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
New pill could tame ulcerative colitis Flare-Ups
Disease control Recruiting nowThe goal of this study is to learn if tilpisertib fosmecarbil (formerly known as GS-5290) is effective and safe in treating participants with moderate to severe ulcerative colitis. The study will compare participants in different treatment groups treated with tilpisertib fosmecar…
Phase: PHASE2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New study tracks mylotarg safety in AML patients
Disease control Recruiting nowThe purpose of this clinical trial is to learn about the safety and effects of the study medicine (called Mylotarg) for the potential treatment of acute myeloid leukemia (AML). AML is a disease that affects the body's white blood cells. This study is seeking participants in Korea…
Sponsor: Pfizer • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New combo therapy aims to curb meth use in canadian trial
Disease control Recruiting nowThe goal of this clinical trial is to learn if administering a high dose stimulant with Contingency Management reduces days of use in adults who use methamphetamine better than the usual treatment provided by the clinic. The main questions the trial aims to answer are: Is a hig…
Phase: PHASE2 • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New drug combo trial targets Hard-to-Treat breast and ovarian cancers
Disease control Recruiting nowThis study is designed to evaluate AZD8421 alone and in combination with selected targeted anti-cancer drugs in patients with ER+HER2- advanced breast cancer, and patients with metastatic high-grade serious ovarian cancer.
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New brain bleed treatment shows promise in massive review
Disease control Recruiting nowThis multi-center retrospective cohort study aims to investigate the real-world outcomes of chronic subdural hematoma treated with MMAE, including clinical effectiveness, recurrence rates, and safety profile.
Sponsor: Montefiore Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
AI and a smartphone app may let kids with asthma skip clinic visits
Disease control CompletedThe main purpose of this study is to look at whether clinicians and their patients with asthma can satisfactorily perform remote asthma management at home (not visiting clinic) by using an artificial intelligence tool called Asthma-Guidance and Prediction System combined with a h…
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New drug AZD0305 takes on multiple myeloma in early trial
Disease control Recruiting nowThis is a Phase I/II, modular, open-label, multicenter, dose escalation, and dose expansion/optimization study to evaluate the safety, tolerability, PK, immunogenicity, pharmacodynamics and efficacy of AZD0305 as monotherapy and in combination with other anticancer agents in part…
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New anthrax vaccine moves forward in human trials
⭐️ VACCINE ⭐️ OngoingThis randomized, phase 2, double-blinded, multicenter study is designed to assess the safety and immune response kinetics of CYFENDUS™ (henceforth AV7909) administered on 2 primary series vaccination schedules followed by 6- and 12-month boosters.
Phase: PHASE2 • Sponsor: Biomedical Advanced Research and Development Authority • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:07 UTC
-
Could a Low-Calorie diet ease heart failure symptoms?
Disease control CompletedHeart failure with preserved ejection fraction (HFpEF) is a common and serious complication of obesity and type 2 diabetes (T2D). HFpEF occurs when the heart muscle unable to relax efficiently to pump the blood around the body. This leads to fluid build-up, breathlessness and ina…
Phase: PHASE2, PHASE3 • Sponsor: University of Leicester • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New electric pulse method tested for stubborn heart rhythm disorder
Disease control OngoingComparison of pulmonary vein and left atrial posterior wall isolation durability and clinical outcome between radiofrequency and pulse field ablation in patients with persistent and longstanding persistent atrial fibrillation.
Phase: NA • Sponsor: University Medical Centre Ljubljana • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New laser device aims to lower eye pressure better in glaucoma surgery trial
Disease control Recruiting nowThe primary study objective is to compare the effectiveness of the combination of phacoemulsification with intraocular lens implant with ELIOS or competitor device in reducing IOP at 12 months postoperatively.
Phase: NA • Sponsor: Elios Vision, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for tough ulcerative colitis cases? experimental drug ALTB-268 enters phase 2 trial
Disease control OngoingALTB-268-201 is a Phase 2a, multicenter, single arm, multiple-dose, open-label study evaluating the efficacy and safety of ALTB-268 in subjects with moderately to severely active UC. The study consists of a Screening Phase, an Induction Phase and a LTE (Long Term Extension)
Phase: PHASE2 • Sponsor: AltruBio Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New scan could slash unnecessary prostate biopsies
Diagnosis Recruiting nowThis project aims to evaluate the role of fully hybrid PET/MRI with 18FPSMA and multiparametric MR imaging (mpMRI) as one-stop approach for the diagnosis of clinically significant prostate cancer (csPCa). Our main hypothesis is that adding 18F-PSMA PET to mpMRI prior to biopsy, …
Phase: PHASE2 • Sponsor: IRCCS San Raffaele • Aim: Diagnosis
Last updated Jun 27, 2026 12:01 UTC
-
Can Custom-Tailored brain zaps beat tough depression?
Symptom relief TerminatedThe aim of this study is to explore the effectiveness and safety of different doses of neural regulation under the guidance of pBFS technology in improving symptoms in patients with moderate to severe depressive disorders.
Phase: NA • Sponsor: Changping Laboratory • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New drug tested before prostate surgery in High-Risk cancer patients
Disease control Recruiting nowTo learn about the safety and effects of a drug called REGN5678 when it is given to patients with high-risk prostate cancer.
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Blood test could personalize chemo for gut cancer patients
Disease control Recruiting nowTo learn if circulating tumor DNA (ctDNA) testing before cytoreductive surgery (CRS) with or without heated intraperitoneal chemotherapy (HIPEC) can show if patients have a low or high risk of the disease returning and help doctors decide if less or more intense chemotherapy is n…
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC